Key facts
- UVX’s last known valuation is $9.0M (Mar 2025).
- It has raised $2.0M; the latest was Later Stage VC ($1.0M) in Mar 2025.
- Notable investors include Flybridge (New York), ventureLAB Innovation Centre, TELUS Global Ventures, Scale Good Fund, Front Row Ventures — 11 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for UVX
- ·The full record, as it builds
Funding rounds
No funding rounds for UVX are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About UVX
Manufacturer of intelligent ceiling devices designed to sanitize air and surfaces continuously. The company offers a platform featuring patented saferay UVC light technology that provides continuous air and surface disinfection without harming humans, enabling healthcare facilities to reduce infection rates and associated costs while maintaining a safe environment for occupants.
- Sector
- Business Products and Services (B2B)
- HQ
- Vancouver, Canada
- Founded
- 2020
- Employees
- 11
- Website
- uvxinc.com/
- Ownership
- Privately Held (backing)
UVX doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in UVX shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on UVX in its N-PORT filings yet. We sweep new filings monthly.